Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunol Rev. 2008 Jun;223:371-90. doi: 10.1111/j.1600-065X.2008.00637.x.

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.

Author information

  • 1Diabetes Center, University of California, San Francisco, CA 94143-0540, USA.

Erratum in

  • Immunol Rev. 2009 May;229(1):388.

Abstract

SUMMARY:

The importance of regulatory T lymphocytes (Tregs) in the control of autoimmunity is now well established in a variety of experimental animal models. In addition, there are numerous studies suggesting that Treg deficits may be an underlying cause of human autoimmune diseases. The emergence of Tregs as an essential component of immune homeostasis provides a potential therapeutic opportunity for active immune regulation and long-term tolerance induction. In this article, we summarize the core basic science and animal model studies of Tregs, review the status of multiple biologic and small molecule chemical compounds to promote Treg development in vivo, and discuss recent advances for the identification and expansion of polyclonal and antigen-specific Tregs for adoptive immunotherapy. In summary, the review provides an in-depth analysis and highlights the challenges and opportunities for immune intervention with Treg-based therapeutics.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center